Skip to main content
. 2017 Dec 18;29(2):410–419. doi: 10.1021/acs.bioconjchem.7b00726

Figure 7.

Figure 7

In vivo metabolic stabilities of 68Ga–NOTA–Aca–BBN7–14 and 68Ga–NOTA–PEG3–RM26, respectively, in serum at 5 min after injection and urine and tumor at 30 min after injection. (A) Stability of 68Ga–NOTA–Aca–BBN7–14 in serum at 5 min post-injection. (B) Stability of 68Ga–NOTA–PEG3–RM26 in serum at 5 min post-injection. (C) Stability of 68Ga–NOTA–Aca–BBN7–14 in tumor at 30 min post-injection. (D) Stability of 68Ga–NOTA–PEG3–RM26 in tumor at 30 min post-injection. (E) Stability of 68Ga–NOTA–Aca–BBN7–14 in urine at 30 min post-injection. (F) Stability of 68Ga–NOTA–PEG3–RM26 in urine at 30 min post-injection.